Pharma and Biotech

Thailand: Updated Dosage Limits for Drugs Containing Fat-Soluble Vitamins

The Ministry of Public Health in Thailand has unveiled a draft notification outlining updated dosage...

Read more

Pharma and Biotech

EU Committees Adopt Position on Green Claims Directive: Penalties, Verifica…

The Internal Market and Environment committees of the EU Parliament have adopted their position on...

Read more

Pharma and Biotech

Proposed changes to the Pharmaceutical Advertising Advisory Board (PAAB) Co…

Health Canada is currently scrutinizing a significant revamp of pharmaceutical advertising standards proposed by the...

Read more

Pharma and Biotech

TGA Seeks Input: Adoption of International Scientific Guidelines

The Therapeutic Goods Administration (TGA) Australia is actively seeking public input on the adoption of...

Read more

Food and Nutrition

EU Draft Regulation: Banning BPA in Food Contact Materials

The European Commission presents a draft regulation aiming to restrict the use of bisphenol A...

Read more

Food and Nutrition

UK Government Report on Malaysian Palm Oil and EU’s BPA Ban Draft

The UK Government has released an official report highlighting key findings and a positive verdict...

Read more

Food and Nutrition

Belgium Updates Authorized Plants in Food and Supplements

Belgium has published a significant update through an Order that revises the list of plants...

Read more

Food and Nutrition

Ukraine Aligns Dietary Supplement Regulation with EU Standards

Ukraine informs the World Trade Organization of a draft law aligning its dietary supplement regulation...

Read more

Pharma and Biotech

Thai FDA’s Proposed Draft Notification: Annual Safety Reports for Con…

Thai FDA proposes a draft Notification mandating annual safety reports for terminated or completed clinical...

Read more

Pharma and Biotech

US FDA Eases Informed Consent for Minimal Risk Clinical Trials

FDA Implements 21st Century Cures Act: Effective 30 days post-publication, ensuring rights and safety of...

Read more

Have a
regulatory affairs
challenge?

Regulatory Affair Icon